Erratum: A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer (Oncogene (2005) 24 (4037-4051) DOI: 10.1038/sj.onc.1208602);A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer

Oncogene

Volumn 24, Issue 25, 2005, Pages 4037-4051

  Joyce, Johanna A ^a,c   Freeman, Craig ^b   Meyer Morse, Nicole ^a   Parish, Christopher R ^b   Hanahan, Douglas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Biology and Environment   (Australia)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Angiogenesis; Heparan sulfate binding proteins; Heparanase; Invasion; Mouse model; Pancreatic neuroendocrine cancer

Indexed keywords

BINDING PROTEIN; CHEMOKINE; GROWTH FACTOR; HEPARAN SULFATE; HEPARANASE; MESSENGER RNA; OLIGOSACCHARIDE; PI 88; PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; COW; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING;

MAMMALIA;

EID: 20444394457     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208770     Document Type: Erratum

References (56)

1. Bartlett MR, Cowden WB and Parish CR. (1995). J. Leukoc. Biol., 57, 207-213.
2. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D. (2000). Nat. Cell Biol., 2, 737-744.
3. Bergers G, Javaherian K, Lo KM, Folkman J and Hanahan D. (1999). Science, 284, 808-812.
4. Bergers G, Song S, Meyer-Morse N, Bergsland E and Hanahan D. (2003). J. Clin. Invest, 111, 1287-1295.
5. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J and Zako M. (1999). Annu. Rev. Biochem., 68, 729-777.
6. Brekken RA, Huang X, King SW and Thorpe PE. (1998). Cancer Res., 58, 1952-1959.
7. Cochran S, Li C, Fairweather JK, Kelt WC, Coombe DR and Ferro V. (2003). J. Med. Chem., 46, 4601-4608.
8. Compagni A, Wilgenbus P, Impagnatiello MA, Gotten M and Christofori G. (2000). Cancer Res., 60, 7163-7169.
9. D'Amore MA, Gallagher PM, Korfhagen TR and Ganschow RE. (1988). Biochemistry, 27, 7131-7140.
10. Dempsey LA, Plummer TB, Coombes SL and Platt JL. (2000). Glycobiology, 10, 467-475.
11. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D and Baekkeskov S. (1988). Proc. Natl. Acad. Sci. USA, 85, 9037-9041.
12. Elson DA, Thurston G, Huang LE, Ginzinger DG, McDonald DM, Johnson RS and Arbeit JM. (2001). Genes Dev., 15, 2520-2532.
13. Ferro V, Fewings K, Palermo MC and Li C. (2001). Carbohydrate Res., 332, 183-189.
14. Folkman J, Watson K, Ingber D and Hanahan D. (1989). Nature, 339, 58-61.
15. Francis DJ, Parish CR, McGarry M, Santiago FS, Lowe HC, Brown KJ, Bingley JA, Hayward IP, Cowden WB, Campbell JH, Campbell GR, Chesterman CN and Khachigian LM. (2003). Circ. Res., 92, e70-e77.
16. Freeman C and Parish CR. (1997). Biochem. J., 325 (Part 1), 229-237.
17. Freeman C and Parish CR. (1998). Biochem. J., 330 (Part 3), 1341-1350.
18. Friedmann Y. Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I and Pappo O. (2000). Am. J. Pathol., 157, 1167-1175.
19. Giraudo E, Inoue M and Hanahan D. (2004). J. Clin. Invest., 114, 623-633.
20. Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, Friedmann Y, Schirrmacher V, Mitrani E and Vlodavsky I. (2002). Proc. Natl. Acad. Sci. USA, 99, 10031-10036.
21. Haimov-Kochman R, Friedmann Y, Prus D, Goldman-Wohl DS, Greenfield C, Anteby EY, Aviv A, Vlodavsky I and Yagel S. (2002). Mol. Hum. Reprod, 8, 566-573.
22. Hanahan D. (1985). Nature, 315, 115-122.
23. Hileman RE, Fromm JR, Weiler JM and Linhardt RJ. (1998). BioEssays, 20, 156-167.
24. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ and Parish CR. (1999). Nat. Med., 5, 803-809.
25. Inoue M, Hager JH, Ferrara N, Gerber HP and Hanahan D. (2002). Cancer Cell., 1, 193-202.
26. Iozzo RV and San Antonio JD. (2001). J. Clin. Invest., 108, 349-355.
27. Ishai-Michaeli R, Eldor A and Vlodavsky I. (1990). Cell Regul., 1, 833-842.
28. Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai FY, Greenbaum DC, Hager JH, Bogyo M and Hanahan D. (2004). Cancer Cell., 5, 443-453.
29. Kalluri R. (2003). Nat. Rev. Cancer, 3, 422-433.
30. Kelly T, Miao HQ, Yang Y, Navarro E, Kussie P, Huang Y, MacLeod V, Casciano J, Joseph L, Zhan F, Zangari M, Barlogie B, Shaughnessy J and Sanderson RD. (2003). Cancer Res., 63, 8749-8756.
31. Khachigian LM and Parish CR. (2004). Cardiovasc. Drug Rev., 22, 1-6.
32. Kim AW, Xu X, Hollinger EF, Gattuso P, Godellas CV and Prinz RA. (2002). J. Gastrointest. Surg., 6, 167-172.
33. Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, Vlodavsky I, Zimmermann A and Buchler MW. (2001), Cancer Res., 61, 4655-4659.
34. Levidiotis V, Freeman C, Tikellis C, Cooper ME and Power DA. (2004). J. Am. Soc. Nephrol., 15, 68-78.
35. Lopez T and Hanahan D. (2002). Cancer Cell, 1, 339-353.
36. Marchetti D, Li J and Shen R. (2000). Cancer Res., 60, 4767-4770.
37. Marchetti D and Nicolson GL. (1997). Adv. Enzyme. Regul., 37, 111-134.
38. Maxhimer JB, Quiros RM, Stewart R, Dowlatshahi K, Gattuso P, Fan M, Prinz RA and Xu X. (2002). Surgery, 132, 326-333.
39. Nakajima M, Irimura T and Nicolson GL. (1988). J. Cell. Biochem., 36, 157-167.
40. Ornitz DM. (2000). BioEssays, 22, 108-112.
41. Parangi S, Dietrich W, Christofori G, Lander ES and Hanahan D. (1995). Cancer Res., 55, 6071-6076.
42. Parish CR, Freeman C, Brown KJ, Francis DJ and Cowden WB. (1999). Cancer Res., 59, 3433-3441.
43. Parish CR, Freeman C and Hulett MD. (2001). Biochim. Biophys. Acta, 1471, M99-M108.
44. Powers CJ, McLeskey SW and Wellstein A. (2000). Endocr. Relat. Cancer, 7, 165-197.
45. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J and Iruela-Arispe ML. (2001). Proc. Natl. Acad. Sci. USA, 98, 12485-12490.
46. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ and Mohammadi M. (2000). Mol. Cell, 6, 743-750.
47. Soker S, Goldstaub D, Svahn CM, Vlodavsky I, Levi BZ and Neufeld G. (1994). Biochem. Biophys. Res. Commun., 203, 1339-1347.
48. Tang W, Nakamura Y, Tsujimoto M, Sato M, Wang X, Kurozumi K, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K. (2002). Mod. Pathol., 15, 593-598.
49. Tumova S, Woods A and Couchman JR. (2000). Int. J. Biochem. Cell Biol., 32, 269-288.
50. Uno F, Fujiwara T, Takata Y, Ohtani S, Katsuda K, Takaoka M, Ohkavva T, Naomoto Y, Nakajima M and Tanaka N. (2001). Cancer Res., 61, 7855-7860.
51. Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P and Fuks Z. (1991). Trends Biochem. Sci., 16, 268-271.
52. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L and Pecker I. (1999). Nat. Med., 5, 793-802.
53. Vlodavsky I, Miao HQ, Medalion B, Danagher P and Ron D. (1996). Cancer Metast. Rev., 15, 177-186.
54. Yurchenco PD and Schittny JC. (1990). FASEB J., 4, 1577-1590.
55. Zcharia E, Metzger S, Chajek-Shaul T, Friedmann Y, Pappo O, Aviv A, Elkin M, Pecker I, Peretz T and Vlodavsky I. (2001). J. Mammary Gland Biol. Neoplasia, 6, 311-322.
56. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I and Ilan N. (2003). Cancer Res., 63, 7733-7741.